The insider sell cluster is small relative to market cap and follows a strong earnings report, likely routine option exercises and diversification, not a bearish signal. CEO's cashless exercise pattern (same-day sale of exercised shares) is standard for tax coverage. Monitor for any follow-on SC13D activist filing or next 10-K for unexpected risk disclosures, but this cluster alone does not warrant action.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 17 $124.41entry
- T+1 · 3mo ago −6.68%α −6.00% · $116.10
- T+5 · 3mo ago +13.17%α +14.36% · $140.80
- T+20 · 2mo ago +11.00%α +12.98% · $138.10
- T+60 · 6d ago +6.21%α +9.15% · $132.13
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Multiple Twist Bioscience insiders, including CEO Emily Leproust, sold a combined $6.37M of stock over a 7-day window. The CEO's sales were part of a same-day cashless exercise of 19,952 options, while Director Robert Chess sold $2M and Dennis Cho sold $1.56M. These sales come 12 days after a strong Q3 earnings beat and raised guidance, likely representing routine portfolio diversification following a significant stock run-up.
Key Financial Metrics
Key Facts
- Total insider sales of $6.37M over 7-day window
- CEO Leproust sold 19,952 shares for $2.50M as part of a same-day option exercise (cashless)
- Director Robert Chess sold 18,400 shares for $2.04M
- See Remarks executive Dennis Cho sold 14,200 shares for $1.56M
- Sales occurred 12 days after Q3 FY2026 earnings beat ($118.4M vs $114.5M consensus) and guidance raise
- Cluster is predominantly sell-side; no open-market purchases in the window
- Total sales represent ~0.08% of Twist's $7.9B market cap
- Recent 30-day insider activity shows 4 sells totaling $19.0M prior to this cluster
Financial Impact
Insider selling cluster of $6.37M represents approximately 0.08% of Twist's $7.9B market cap, well below the 0.1% materiality threshold. No evidence of panic selling or broad-based insider exodus.
Risk Factors
- CEO sold 100% of her exercise-day shares, a modest concern if this becomes a regular pattern
- Director Chess's $2M sale is the largest non-CEO transaction and could indicate some board-level selling pressure
- No insider buying anywhere in the cluster to offset the sell signal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TWST-1786775003123 |
Track record
47 reports on TWST
8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $105.04 +0.01% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $105.04 −0.11% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $105.04 +0.06% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $105.04 −0.54% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $105.04 +0.98% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $105.04 −20.50% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $105.04 −13.04% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $105.04 −12.91% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers